CIIE brings huge opportunity for health care in China

British-Swedish pharmaceutical multinational AstraZeneca announced the expansion of its strategic partnership with Shanghai municipal government to upgrade its Shanghai research and development platform to a global R&D center during the ongoing second China International Import Expo (CIIE).
"The government has invested a lot in terms of building health care institutions and infrastructure, especially in grassroots institutions. We see tremendous opportunities, both in terms of the underlying disease burden and commitment of the government to improving health care. " Michael M. Lai, General Manager of AstraZeneca, said at the CIIE.
It also announced it will establish an artificial intelligence innovation center based in the city's Jing'an district to focus on areas such as new drug development, AI-powered healthcare and big-data-integrated services to ultimately further promote the development of local healthcare innovation.
Today's Top News
- China's industrial profits down 1.8% in H1
- Thailand responds to Trump's ceasefire call
- Recall vote shows DPP's manipulation runs against Taiwan people's will: mainland spokesperson
- Top DPRK leader visits China-DPRK Friendship Tower
- China proposes global cooperation body on AI
- Scholars propose inclusive human rights framework
Most Viewed
- 2025 World AI Conference kicks off in Shanghai
- China's Village Super League resumes after floods
- Highlights of Xi's remarks at meeting with EU leaders
- Xi: Nation to expand opening-up
- France charges Telegram CEO Durov: prosecutor